Close
Nordic 9Nordic 9

Æra Strategic Innovation (investor - Others)

Norway era.as
See something wrong or missing? Let us know
Offices:Oslo
Average round investment:101.7k USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: Norway Mycela
Mostly invests in: Norway Norway (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Æra Strategic Innovation

Name Criteria
Norway Bykuba AS
73%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden E14 Invest
72%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Norway
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Sweden Miun Venture
70%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Vasa Angels
70%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Nicklas Berild Lundblad
70%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Andreas Krohn
70%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Västkusten Affärsänglar
70%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Denmark Christopher Olesen
68%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Spain Genesis Biomed Ventures
68%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Switzerland Venture Kick
67%
  • Range for average deal size: < 0.5M USD
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 2.9
  • Active last 12 months: Yes
Top